Among Black patients with suppressed HIV, estimated glomerular filtration rate by cystatin C appears to provide clinically ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

H.C. Wainwright lowered the firm’s price target on PepGen (PEPG) to $16 from $26 and keeps a Buy rating on the shares after the company shared the safety reports from the CONNECT1-EDO51, the Phase 2, ...

Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.

H.C. Wainwright adjusted its financial outlook for PepGen Inc. (NASDAQ:PEPG), reducing the price target to $16.00 from the ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

After hours: January 28 at 5:47:59 p.m. EST Loading Chart for GFR ...

The following is a summary of “Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study,” published in the January 2025 issue of Cardiology by ...

South Korea: A study of over 1.9 million patients with type 2 diabetes (T2D) found that glomerular hyperfiltration (GHF) was ...

Because time to relapse was similar between the two treatments, the researchers said cyclophosphamide came out on top as the ...

Smoking: Damages kidney blood vessels and reduces function. There are several ways to keep our kidneys healthy: A healthy ...